'America First’ Non-Profit Points To USPTO And FDA For Patent Abuse

The Organization Provided Several Recommendations To Tackle Patent Loopholes

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.